AbbVie, Inc.
No hay operaciones
Títulos de deuda corporativa
A continuación se muestra la lista de bonos de AbbVie, Inc., ordenados según su rendimiento al vencimiento. Los inversores suelen optar por los bonos de una empresa por su mayor estabilidad en períodos de volatilidad del mercado. Analice los precios, los rendimientos y otras estadísticas para tomar decisiones de inversión fiables.
Símbolo | YTM % | Volumen | Precio % | Cupón % | Fecha de vencimiento | Imp. pendiente | Valor nominal | Imp. mín. denom. | Emisor |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,40% | 12 K | 83,25% | 4,850% | 2044-06-15 | 65,23 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,38% | 124 K | 81,98% | 4,625% | 2042-10-01 | 67,49 M USD | 1.000,00 USD | 2.000,00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,79% | 250 K | 91,22% | 4,550% | 2035-03-15 | 107,65 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
| 5,74% | 10,05 M | 96,22% | 5,500% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,65% | 11,79 M | 96,34% | 5,400% | 2054-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,63% | 1,39 M | 82,05% | 4,250% | 2049-11-21 | 5,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,63% | 2,32 M | 99,53% | 5,600% | 2055-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,61% | 2,44 M | 90,51% | 4,875% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,61% | 0 | 86,03% | 4,450% | 2046-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,58% | 0 | 89,61% | 4,700% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,56% | 400 K | 90,50% | 4,750% | 2045-03-15 | 827,09 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,52% | 2,52 M | 92,24% | 4,850% | 2044-06-15 | 1,01 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,49% | 716 K | 98,55% | 5,350% | 2044-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,45% | 0 | 88,48% | 4,400% | 2042-11-06 | 2,6 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,40% | 376 K | 91,49% | 4,625% | 2042-10-01 | 389,22 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 5,20% | 6,06 M | 88,70% | 4,050% | 2039-11-21 | 4 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,91% | 0 | 95,09% | 4,300% | 2036-05-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,82% | 0 | 97,58% | 4,500% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,82% | 5,44 M | 98,10% | 4,550% | 2035-03-15 | 1,68 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,80% | 1,9 M | 102,91% | 5,200% | 2035-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,68% | 5,5 M | 102,44% | 5,050% | 2034-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,25% | 1,46 M | 103,09% | 4,950% | 2031-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,10% | 1,06 M | 102,92% | 4,875% | 2030-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,06% | 11,74 M | 96,99% | 3,200% | 2029-11-21 | 5,44 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 4,00% | 2,74 M | 102,37% | 4,800% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,95% | 2,22 M | 100,75% | 4,250% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,93% | 0 | 99,81% | 3,200% | 2026-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,85% | 3,09 M | 101,61% | 4,650% | 2028-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,83% | 20,09 M | 99,34% | 2,950% | 2026-11-21 | 3,99 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,82% | 19,05 M | 101,06% | 4,800% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,64% | 0 | 95,34% | 2,125% | 2029-06-01 | 36,46 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
| 3,62% | 0 | 97,43% | 2,625% | 2028-11-15 | 72,11 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS | |
| 3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 2,99% | 0 | 90,86% | 1,250% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,59% | 0 | 98,52% | 2,125% | 2029-06-01 | 506,09 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| 2,53% | 0 | 98,91% | 2,125% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,50% | 0 | 100,32% | 2,625% | 2028-11-15 | 427,79 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| 2,40% | 0 | 97,16% | 0,750% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
| −5,92% | 0 | 98,80% | 2,950% | 2026-11-21 | 9,24 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
| — | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |